Monthly Archives: December 2020

An mRNA Vaccine against SARS-CoV-2: Phase I findings

For those interested, this article see attached just appeared in N Engl J Med This article describes the Phase 1, dose-escalation, open-label trial — including 45 healthy adults, 18 to 55 years of age, who received two vaccinations, 28 days … Continue reading

Posted in Center for Environmental Genetics | Comments Off on An mRNA Vaccine against SARS-CoV-2: Phase I findings